Moxonidine improves glycaemic control in mildly hypertensive, overweight type 2 diabetic patients.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001786:Blood Glucose; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000627:therapeutic use*; D050177:Overweight; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D001786:Blood Glucose; D007093:Imidazoles; C043482:moxonidine